Charissa Borja-Tabora
About
In The Last Decade
Charissa Borja-Tabora
20 papers receiving 273 citations
Peers
Comparison fields: 5 of 42
- Epidemiology 198
- Infectious Diseases 108
- Microbiology 82
- Public Health, Environmental and Occupational Health 70
- Health 34
Countries citing papers authored by Charissa Borja-Tabora
This map shows the geographic impact of Charissa Borja-Tabora's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charissa Borja-Tabora with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charissa Borja-Tabora more than expected).
Fields of papers citing papers by Charissa Borja-Tabora
This network shows the impact of papers produced by Charissa Borja-Tabora. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charissa Borja-Tabora. The network helps show where Charissa Borja-Tabora may publish in the future.
Co-authorship network of co-authors of Charissa Borja-Tabora
This figure shows the co-authorship network connecting the top 25 collaborators of Charissa Borja-Tabora. A scholar is included among the top collaborators of Charissa Borja-Tabora based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charissa Borja-Tabora. Charissa Borja-Tabora is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 4 | |
| 3 | 9 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | 7 | |
| 7 | 14 | |
| 8 | 1 | |
| 9 | 10 | |
| 10 | 4 | |
| 11 | 10 | |
| 12 | 43 | |
| 13 | 13 | |
| 14 | 15 | |
| 15 | 16 | |
| 16 | 43 | |
| 17 | 35 | |
| 18 | 21 | |
| 19 | Immunogenicity and safety of a varicella vaccine, Okavax, and a trivalent measles, mumps and rubella vaccine, MMR-II, administered concomitantly in healthy Filipino children aged 12-24 months. | 5 |
| 20 | The new DTPw-HBV-Hib combination vaccine can be used at the who schedule with a monovalent dose of hepatitis B vaccine at birth. | 20 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.